Loading...

Home
ETF
FBLG

FBLG

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

FBLG News

FibroBiologics Unveils Preclinical Data for Psoriasis Treatment

May 22 2026Newsfilter

FibroBiologics Files New Patent for Oral Therapeutics Delivery System

May 18 2026Newsfilter

FibroBiologics Expands Therapeutic Platform to Address Hantavirus

May 11 2026Newsfilter

FibroBiologics Reports Positive Results for Burn Treatment

May 05 2026NASDAQ.COM

FibroBiologics Releases First Batch of CYWC628 Drug for Clinical Trials

May 04 2026Newsfilter

FIBROBIOLOGICS UNVEILS CYWC628 DRUG FOR PHASE 1/2 CLINICAL TRIAL ON DIABETIC FOOT ULCERS

May 04 2026moomoo

FibroBiologics Reports Q1 2026 Financial Results and Corporate Update

Apr 30 2026Newsfilter

FibroBiologics Reports Q1 2026 Financial Results with $5M Loss

Apr 30 2026seekingalpha

FibroBiologics Advances Phase 1/2 Clinical Trial for CYWC628

Apr 30 2026Yahoo Finance

FibroBiologics Presents Psoriasis Data at SID 2026

Apr 30 2026Newsfilter

FibroBiologics Regains Nasdaq Compliance with Key Requirements Met

Apr 20 2026seekingalpha

FibroBiologics Unveils Data on Reversing Immune Decline

Apr 10 2026Newsfilter

FibroBiologics Achieves Key Milestone with CYWC628 Drug Batch Manufacturing

Apr 01 2026NASDAQ.COM

FibroBiologics Prices Public Offering at $1.32 per Share

Apr 01 2026Newsfilter

FibroBiologics Prices Public Offering at $1.32 per Share

Apr 01 2026Yahoo Finance

FibroBiologics Files for $5M Public Offering Amid Reverse Split

Mar 30 2026seekingalpha